🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

An important aspect of cancer care

As we go well into the second month of Chai for Cancer’s Season 11 my heartfelt gratitude to all those who have helped kick start the campaign. Raise your Cup too and Drink to a Cause . Bring Hope & Dignity into the lives of patients living with cancer and on life long treatment

This was an amazing read!! 🔥 🔥 Topical JAK inhibition blocks the pro-inflammatory cascade initiated in keratinocytes by EGFRi and helps with the amelioration of EGFRi-induced skin rash ❗️ A terrible AE that our patients have to deal with. Have seen many cases where the rash

Starting off the session ESMO - Eur. Oncology #ESMO24 Arvind Dasari, MD, MS MD Anderson Cancer Center 👏! Should we revise AJCC staging for #coloncancer with the inclusion of #ctDNA #MRD positivity? The data looks impressive and suggests we need to revise! #cancer #cancerresearch #crcsm

Always exciting to see new targets in GI cancers....phase 1 data cautiously optimistic..

Well said 👏 even "low" grade tox can be constant and functionally and #QoL impactful. #tolerable is in the eyes of the patient, not provider Nicole Kuderer, MD, MS, FASCO 🌎🇺🇸🇪🇺🇺🇦🌏 We must continue to do better. ASCO PallOnc Community of Practice #supponc #pallonc.

A sobering timeline to be certain for #pancsm survivors. We must never tire in our search for effective options for these patients #GIonc Pamela Kunz, MD, FASCO Shaalan Beg MD MBA FASCO #ESMOGI24

Adjuvant Chemotherapy and Chemoradiation in Gallbladder Cancer jamanetwork.com/journals/jamao… Amol Patel Dr (Prof). Vijay Patil Vanita Noronha, MBBS MD DM Shailesh V. Shrikhande Ind J Med Ped Oncology South Asian Journal Of Cancer Viraj Lavingia Sirohi

Join us now the ENETS - NANETS webinar - starting right now! Still time to log in at my.enets.org and learn about "New insights, directions & signals" for #NET practice. No myENETS account yet? Create one for free here: my.enets.org/create_account. See you there!

Join us @ the 23rd Banff Pathology Course (Oct 9-12). I'll share the podium with Anthony J Gill, WC Faquin, MD, PhD & a cavalcade of local experts from U Calgary & University of Alberta--luxuriating over endocrine pathology in a pristine setting. In MiNEN opinion, it'll be a blast! banffpathologycourse.com

Namrata (Neena) Vijayvergia MD Let's Win Pancreatic Cancer 💜 A lot of people underestimate NETS because they do not grow as quickly as other tumors. But the impact on quality of life and burden of symptoms can be tremendous. More/better treatments needed #pancchat

This newly published review article summarizes the current clinical status of well-differentiated gastroenteropancreatic neuroendocrine tumors across diagnostic and treatment modalities. acsjournals.onlinelibrary.wiley.com/doi/full/10.10… Jaydira Del Rivero, MD OncoAlert

Chemo resistance plagues poorly differentiated #NECs. Guided by Whetstine Lab and collaboration with Heloisa Soares MD and Renuka Iyer, clinicaltrials.gov/study/NCT05420… is trying epigenetic modification with #Iadademstat to improve chemo benefit Fox Chase Cancer Center

📣 ATTENTION TRAINEES! If you’re a trainee interested in Neuroendocrine Neoplasms, I really hope to see you at the NANETS annual multi-disciplinary symposium. ⏱️Nov 21-23,2024 📍Chicago, IL REGISTRATION IS OPEN!! We are planning to organize a special meet-up to foster

If for-profit healthcare is the model USA votes for, then why ban physical owned ,physician run hospitals. Let people who became physicians because they care for patients also run hospitals. Better than private equity backed corporates and for profit health systems

🚨🚨POD1UM-303/InterAACT 2🚨🚨 Inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal 🔎Randomized: Carbo/Taxol vs. Carbo/Taxol + retifanlimab Addition of retifanlimab associated with: ✅⬆️ OS 29 vs 23 m ✅⬆️ PFS 9 vs 7 m 🔥New SOC!!🔥 #ESMO24

Biological basis to treat #Neuroendocrine 🦓 neoplasms at #ESMO24 Always learning from Jaume Capdevila . Precision medicine is still far from the clinic but with the support of all agents involved I’m confident we will find something soon!!! Grupo GETNE ESMO - Eur. Oncology OncoAlert

First step in increasing representation of a diverse population and increasing access to drugs

Excited to join you all in less than an hour! NET CANCER FOUNDATION

Amazing mentors, colleagues and patients as well at UI Holden Comprehensive Cancer Center that I have learnt so much from ! So many NETologists have trained at Iowa including yourself Udhayvir Grewal . Legacy of O'Dorisios!